
浏览全部资源
扫码关注微信
1.河南中医药大学 第二临床医学院,郑州 450002
2.河南省中医院,郑州 450002
蔡一宁,硕士,从事中医药治疗耳鼻咽喉疾病研究 ,E-mail:caiiiyn@163.com
蔡纪堂,主任医师,从事中医药治疗耳鼻咽喉疾病研究,E-mail:caijitang@163.com
收稿日期:2021-08-08,
网络出版日期:2022-01-11,
纸质出版日期:2022-05-05
移动端阅览
蔡一宁,吴紫陆,王俊杰等.鼻康复调控IL-35/STAT3抑制嗜酸性粒细胞活化及免疫功能抗变应性鼻炎作用机制[J].中国实验方剂学杂志,2022,28(09):110-116.
CAI Yi-ning,WU Zi-lu,WANG Jun-jie,et al.Anti-Allergic Rhinitis Mechanism of Bikangfu via Regulation of IL-35/STAT3, Inhibition of Eosinophil Activation and Improvement of Immune Function[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(09):110-116.
蔡一宁,吴紫陆,王俊杰等.鼻康复调控IL-35/STAT3抑制嗜酸性粒细胞活化及免疫功能抗变应性鼻炎作用机制[J].中国实验方剂学杂志,2022,28(09):110-116. DOI: 10.13422/j.cnki.syfjx.20220993.
CAI Yi-ning,WU Zi-lu,WANG Jun-jie,et al.Anti-Allergic Rhinitis Mechanism of Bikangfu via Regulation of IL-35/STAT3, Inhibition of Eosinophil Activation and Improvement of Immune Function[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(09):110-116. DOI: 10.13422/j.cnki.syfjx.20220993.
目的
2
探究鼻康复调控白细胞介素-35(IL-35)/信号转导及转录激活因子3(STAT3)、抑制嗜酸性粒细胞活化抗变应性鼻炎作用机制研究。
方法
2
100例患者随机分为对照组和观察组,各50例。对照组给予糠酸莫米松鼻喷雾剂,观察组给予鼻康复鼻腔填塞治疗,疗程均为28 d。治疗前后分别观察两组临床疗效、鼻部分类及症状视觉模拟量表(VAS)评分变化;采用酶联免疫吸附测定法(ELISA)检测两组患者血清及鼻分泌物中炎性因子(IL-4、IL-10、IL-17、IL-35)表达水平及嗜酸性粒细胞趋化因子(Eotaxin)、趋化因子受体3(CCR3)含量;采用实时荧光定量聚合酶链式反应(Real-time PCR)检测STAT1、STAT3、STAT4表达水平;分别采用ELISA及流式细胞术检测患者血清中免疫球蛋白G(IgG)含量及CD4
+
/CD8
+
。
结果
2
治疗后,与本组治疗前比较,两组患者血清及鼻分泌物中IL-4、IL-17水平降低,IL-10、IL-35水平升高(
P
<
0.05,
P
<
0.01);鼻分泌物中STAT1、STAT2、STAT3 mRNA水平均明显降低(
P
<
0.05);IgG、CD4
+
/CD8
+
均有所降低,差异具有统计学意义(
P
<
0.05,
P
<
0.01)。治疗后,与对照组比较,观察组的血清及鼻分泌物中IL-4、IL-17水平降低,IL-10、IL-35水平升高(
P
<
0.05);治疗后,与对照组比较,观察组显著抑制STAT1、STAT3、STAT4表达(
P
<
0.05);治疗后,与对照组比较,观察组血清CD4
+
/CD8
+
及免疫球蛋白G(IgG)水平降低(
P
<
0.05,
P
<
0.01)。项目执行期间两组患者心、肝、肾功能及血尿常规未出现异常改变。
结论
2
鼻康复对变应性鼻炎具有良好疗效,其作用机制可能与调控IL-35/STAT3通路、抑制嗜酸性粒细胞活化及改善相关免疫功能有关。
Objective
2
To investigate the mechanism of interleukin-35(IL-35)/signal transducer and activator of transcription 3(STAT3)inhibition of eosinophil activation against allergic rhinitis(AR) by Bifukang.
Method
2
One hundred patients were randomly divided into a control group and a treatment group,50 cases in each group. The control group was given mometasone furoate nasal spray,and the treatment group was given Bifukang by nasal packing. The course of treatment was 28 days. The clinical efficacy,nasal classification and visual analogue scale(VAS) score of the two groups were observed before and after treatment. Enzyme linked immunosorbent assay(ELISA) was used to detect the expression levels of inflammatory factors [interleukin(IL)-4,IL-10,IL-17,IL-35] and Eotaxin and CC chemokine receptor-3(CCR3)in serum and nasal secretion of the two groups. The expression levels of STAT1,STAT3 and STAT4 were detected by real-time polymerase chain reaction(Real-time PCR).The content of immunoglobulin G(IgG) and the ratio of CD4
+
/CD8
+
were detected by ELISA and flow cytometry.
Result
2
After treatment, compared with before treatment, the levels of IL-4 and IL-17 in serum and nasal secretion in 2 groups were decreased, while the levels of IL-10 and IL-35 were increased (
P
<
0.05,
P
<
0.01). The expression of STAT1, STAT2 and STAT3 in nasal secretions were significantly decreased (
P
<
0.05). IgG and CD4
+
/CD8
+
were decreased, and the differences were statistically significant (
P
<
0.05,
P
<
0.01).After treatment,compared with the control group,the levels of IL-4 and IL-17 in serum and nasal secretions of the treatment group were decreased,while the levels of IL-10 and IL-35 were increased (
P
<
0.05). The expression of STAT1,STAT3 and STAT4 in the treatment group was significantly inhibited compared with the control group after treatment (
P
<
0.05). In addition, the post-treatment serum CD4
+
/CD8
+
and immunoglobulin G (IgG) levels were reduced in the treatment group compared with those of the control group (
P
<
0.05,
P
<
0.01). During the treatment,there were no abnormal changes in heart,liver,kidney function and routine blood and urine tests in the two groups.
Conclusion
2
Bifukang has a good effect on allergic rhinitis,and its mechanism may be related to the regulation of IL-35/STAT3 pathway,the inhibition of eosinophil activation and the improvement of related immune function.
BRINDISI G , DE VITTORI V , DE NOLA R , et al . The Role of nasal nitric oxide and anterior active rhinomanometry in the diagnosis of allergic rhinitis and asthma: A message for pediatric clinical practice [J]. J Asthma Allergy , 2021 , 14 : 265 - 274 .
GENG B , DILLEY M , ANTERASIAN C . Biologic therapies for allergic rhinitis and nasal polyposis [J]. Curr Allergy Asthma Rep , 2021 , 21 ( 6 ): 36 .
GADELHA F , CAVALCANTI R , VIEIRA G C , et al . Immunomodulatory properties of Musa paradisiaca L.inflorescence in Combined Allergic Rhinitis and Asthma Syndrome(CARAS) model towards NF κ B pathway inhibition [J]. J Funct Foods , 2021 , 83 ( 6 ): 104540 .
JIANG J , MEHRABI NASAB E , ATHARI S M , et al . Effects of vitamin E and selenium on allergic rhinitis and asthma pathophysiology [J]. Respir Physiol Neurobiol , 2021 , 286 : 103614 .
陈璐璐 , 李静波 , 王俊杰 , 等 . 加味补肺白石英散联合鼓膜内注射曲安奈德治疗变应性鼻炎合并渗出性中耳炎的临床疗效 [J]. 中药药理与临床 , 2021 , 37 ( 4 ): 191 - 195 .
DING L F , CHEN Q , LI L , et al . Effects of sublingual immunotherapy on serum IL-17 and IL-35 levels in children with allergic rhinitis or asthma [J]. Chin J Contemp Pediatr , 2014 , 16 ( 12 ): 1206 - 1210 .
SUZUKI M , YOKOTA M , NAKAMURA Y , et al . Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis [J]. Allergol Int , 2017 , 66 ( 2 ): 351 - 356 .
YIN X , REN X , LIU C , et al . The regulatory effect of IL-35 on the balance of Treg/Th17 cells in allergic rhinitis patients [J]. J Clin Otorhinolaryngol Head Neck Surg , 2016 , 30 ( 3 ): 213 .
KIM K , BAE W , LEE H J , et al . Eosinophil-derived neurotoxin as a biomarker in children with allergic rhinitis [J]. J Allergy Clin Immunol , 2021 , 147 ( 2 ): AB132 .
DU Q , WANG R . Effects of Biminkang mixture on AQP5 level in allergic rhinitis rats [J]. IOP Conf Ser EES , 2021 , 692 ( 3 ): 032118 .
中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组 , 中华医学会耳鼻咽喉头颈外科学分会鼻科学组 . 变应性鼻炎诊断和治疗指南(2015年,天津) [J]. 中华耳鼻咽喉头颈外科杂志 , 2016 , 51 ( 1 ): 6 - 24 .
王士贞 . 中医耳鼻喉科学 [M]. 北京 : 中国中医药出版社 , 2003 : 122 - 127 .
中华耳鼻咽喉头颈外科杂志编辑委员会 , 中华医学会耳鼻咽喉科分会 . 变应性鼻炎的诊治原则和推荐方案(2004年,兰州) [J]. 中华耳鼻咽喉头颈外科杂志 , 2005 , 40 ( 3 ): 166 - 167 .
石志红 , 石志福 . 中医对过敏性鼻炎病因病机的认识 [J]. 内蒙古医科大学学报 , 2012 , 34 ( S4 ): 842 - 846 .
黎玉秀 , 张立峰 , 谭智敏 . 从六经辨证论治变应性鼻炎的研究进展 [J]. 世界中医药 , 2021 , 16 ( 11 ): 1750 - 1753,1758 .
郭小燕 . 中医药辨治小儿过敏性鼻炎概况 [J]. 医学信息 , 2015 ( 27 ): 392 - 393 .
段兵权 , 孙永东 . 中医治疗过敏性鼻炎的研究进展 [J]. 基层医学论坛 , 2016 , 20 ( 1 ): 107 - 108 .
郭晓庆 , 朱任良 , 罗秋兰 . 283例变应性鼻炎患者中医体质与证型相关性研究 [J]. 世界中医药 , 2020 , 15 ( 15 ): 2331 - 2335 .
和培举 , 丁玲 , 李莹 . 蔡福养教授运用滋阴法治疗耳鼻咽喉疾病经验 [J]. 中医研究 , 2013 , 26 ( 8 ): 37 - 39 .
王永钦 . 蔡福养教授治疗慢性鼻炎的经验 [J]. 辽宁中医杂志 , 1987 ( 7 ): 2 - 3 .
高磊 , 蔡纪堂 , 王俊杰 , 等 . 鼻康复鼻腔填塞治疗局部变应性鼻炎的疗效分析 [J]. 中医学 , 2021 , 10 ( 2 ): 6 .
蔡纪堂 , 王俊杰 , 王慧敏 . 鼻康复治疗变应性鼻炎临床研究 [J]. 中医学报 , 2016 , 31 ( 8 ): 1209 - 1211 .
柴峰 , 王俊杰 . 鼻康复鼻腔填塞治疗慢性肥厚性鼻炎 [J]. 辽宁中医杂志 , 2011 , 38 ( 5 ): 941 - 942 .
彭林峰 , 桂雄斌 , 王明刚 , 等 . Treg/Th17在变应性鼻炎发病机制中作用的研究进展 [J]. 广西医学 , 2021 , 43 ( 7 ): 868 - 871 .
LI J , LIN X , LIU X , et al . Baicalin regulates Treg/Th17 cell imbalance by inhibiting autophagy in allergic rhinitis [J]. Mol Immunol , 2020 , 125 : 162 - 171 .
WANG J , QIU L , CHEN Y , et al . Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis [J]. Open Med (Wars) , 2021 , 16 ( 1 ): 826 - 832 .
黄榆岚 , 邓志华 , 高思敏 , 等 . 变应性鼻炎患者血清IL-17、IL-25及TNF- α 水平表达及与病情严重程度的关系研究 [J]. 现代生物医学进展 , 2019 , 19 ( 5 ): 911 - 914 .
刘娜 . 类风湿关节炎系统损害及疾病活动与IL-6、IL-17、JAK3、STAT3、MMP-3、MMP-13等相关性临床研究 [D]. 合肥 : 安徽医科大学 , 2017 .
胡玥 , 杨和强 , 刘文峰 , 等 . 慢性鼻-鼻窦炎伴鼻息肉患者病变组织中IL-2和IL-35表达水平及其与Th1/Th2/Th17细胞因子的关系 [J]. 解放军医药杂志 , 2020 , 32 ( 12 ): 103 - 106 .
HE Y , PEI J H , LI X Q , et al . IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC [J]. Biochem Biophys Res Commun , 2021 , 559 : 35 - 41 .
付维 , 蒋卫红 . STAT3转录因子和辅助性T17细胞与变应性鼻炎 [J]. 国际耳鼻咽喉头颈外科杂志 , 2012 , 36 ( 3 ): 146 - 149 .
田从哲 , 杜锦朵 , 肖二彬 . 鼻息肉中IgE、GM-CSF与嗜酸性粒细胞浸润的关系及意义 [J]. 河北职工医学院学报 , 2006 , 23 ( 3 ): 47 - 47 .
朱真真 , 王威清 , 陈玉洁 , 等 . 慢性鼻窦炎伴鼻息肉复发手术时的组织病理学及外周血特征变化 [J]. 中华耳鼻咽喉头颈外科杂志 , 2021 , 56 ( 3 ): 249 - 255 .
吴思仿 , 周丽芹 , 吴峰 . 支气管哮喘患者ICAM-1、EOS水平与病情严重程度的相关性分析 [J]. 临床肺科杂志 , 2019 , 24 ( 5 ): 803 - 806 .
汪美群 . 敲除CCR3基因对变应性鼻炎发病机制影响的实验研究 [D]. 南昌 : 南昌大学 , 2017 .
安海转 , 贾晓霞 , 樊凯 , 等 . CD8 + 调节性T细胞在疾病中的作用 [J]. 中华风湿病学杂志 , 2018 , 22 ( 3 ): 214 - 216 .
0
浏览量
20
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621